AI Podcast Interviews Articles and Reports

Our podcast interviews feature the best and brightest executives and researchers in artificial intelligence today, and each episode highlights current and near-term AI use-cases of value for business leaders. Explore our full list of AI podcast episodes below:

final-updated-Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizolli of V7

Approaching Life Sciences and Retail Challenges from a Data Perspective – with Alberto Rizzoli of V7

Problems in different industries can look quite similar when looked at from the perspective of data. Though diverse business problems originate from distinct domains and needs, they often share a common thread and solution. 

Financial Services Challenges from a Data Perspective – with Bill Waid of FICO@2x-min

Financial Services Challenges from a Data Perspective – with Bill Waid of FICO

Originally founded as Fair, Isaac and Company, FICO is a data analytics company founded in 1956. Based in Bozeman, Montana, the company is focused on credit scoring services, most notably its FICO score, which measures a person's creditworthiness. 

Improving Patient Experiences in Health Insurance Workflows@1x

Improving Patient Experiences in Health Insurance Workflows – with Shane Bray and John Thomas of Uniphore

This interview analysis is sponsored by Uniphore and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Machine Learning and Large Language Models in Healthcare – with Dr. Arta Bakshandeh of Alignment Health@1x

Machine Learning and Large Language Models in Healthcare – with Dr. Arta Bakshandeh of Alignment Health

AI and machine learning have promising potential in the field of healthcare. However, there is one significant hurdle healthcare companies often encounter when trying to implement AI and machine learning. The data architecture of current legacy systems in healthcare settings prevents implementing many use cases and limits a company’s ability to benefit from these technologies fully.

AI Solutions for B2b Customer Experiences – with Shahar Chen of Aquant@2x

AI Solutions for B2B Customer Experiences – with Shahar Chen of Aquant

This interview analysis is sponsored by Aquant was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

The Essentials of Wireless Technology Infrastructure for Automotive Manufacturers – with Don McGuire of Qualcomm@2x-min

The Essentials of Wireless Technology Infrastructure for Automotive Manufacturers – with Don McGuire of Qualcomm

Due to technological advancements, automakers are uniquely positioned to benefit from an industry-wide transformation. Technology now allows a direct connection between car manufacturers and the customers who purchase those cars. Such a relationship has never before been possible in the history of the automotive industry.

How to Think of the Future of Finserv in the Age of GenAI – with Marco Argenti of Goldman Sachs@2x-min

How to Think of the Future of Finserv in the Age of GenAI – with Marco Argenti of Goldman Sachs

With the rapid proliferation of generative AI tools, there is growing anticipation of their potential to bring about notable changes in the financial and business sectors. Examples such as the creation of "the new Bing" – a combination of Microsoft's Bing search engine and ChatGPT, which can generate more reliable and comprehensive answers – and other generative AI tools used to create videos for product design, have all contributed to the expectations within various sectors.

Future of Drug Targeting – Lilly @2x-1-min

The Future of Drug Targeting and Clinical Development with Generative AI Tools – with Ramesh Durvasula of Eli Lilly

Lily is a pharmaceutical giant with a legacy dating back to its founding in 1876 by Colonel Eli Lilly. The company engages more than 9600 employees in research and development, with clinical research conducted in more than 55 countries. As of 2022, the company clocked a revenue of $28,541.4 million and made a net income of $6,244.8 million.